Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells

Journal of Hepatology

Volumn 31, Issue 5, 1999, Pages 791-799

  Rang, Andreas ^a   Günther, Stephan ^a,b   Will, Hans ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Induced posttranscriptional RNA degradation; Intracellular antiviral activity

Indexed keywords

ALPHA INTERFERON; CORE PROTEIN; HEPATITIS B ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA DEGRADATION; VIRUS LOAD; VIRUS REPLICATION;

EID: 0344631691     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80279-7     Document Type: Article

References (35)

1. Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell. 29:1982;403-415.
2. Tuttleman JS, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell. 47:1986;451-460.
3. Hayashi Y, Koike K. Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA. J Virol. 63:1989;2936-2940.
4. Korba BE, Boumpas D, Mann D, Yoakum GH. Direct modulation of HBV surface antigen in a human, HBsAg-producing hepatocellular carcinoma cell line by alpha, beta, or gamma interferons. J Med Virol. 31:1990;272-276.
5. Tur-Kaspa R, Teicher L, Laub O, Itin A, Dagan D, Bloom BR, et al. Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription. J Virol. 64:1990;1821-1824.
6. Caselmann WH, Meyer M, Scholz S, Hofschneider P.H, Koshy R. Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells. J Infect Dis. 166:1992;966-971.
7. Hamasaki K, Nakata K, Nakao K, Mitsuoka S, Tsutsumi T, Kato Y, et al. Interaction of interferon-alpha with interleukin-1 beta or tumor necrosis factor-alpha on hepatitis B virus enhancer activity. Biochem Biophys Res Commun. 183:1992;904-909.
8. Kakumu S, Ito Y, Wakita T, Yoshioka K, Ishikawa T, Takayanagi M, et al. Effects of transforming growth factor-beta 1 against the inhibitory action of interferon on DNA synthesis and viral replication in hepatitis B virus DNA-transfected cell. J Med Virol. 38:1992;62-66.
9. Davis MG, Jansen RW. Inhibition of hepatitis B virus in tissue culture by alpha interferon. Antimicrob Agents Chemother. 38:1994;2921-2924.
10. Berthillon P, Crance JM, Leveque F, Jouan A, Petit MA, Deloince R, et al. Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins by interferon in a human hepatocarcinoma cell line (PLC/PRF/5). J Hepatol. 25:1996;15-19.
11. Chisari FV, Pinkert CA, Milich DR, Filippi P, McLachlan A, Palmiter RD, et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science. 230:1985;1157-1160.
12. Guidotti LG, Matzke B, Schaller H, Chisari FV. High-level hepatitis B virus replication in transgenic mice. J Virol. 69:1995;6158-6169.
13. Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA. 91:1994;3764-3768.
14. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:1996;25-36.
15. Cavanaugh VJ, Guidotti LG, Chisari FV. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol. 71:1997;3236-3243.
16. Tsui LV, Guidotti LG, Ishikawa T, Chisari FV. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc Natl Acad Sci USA. 92:1995;12398-12402.
17. Guidotti LG, Guilhot S, Chisari FV. Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways. J Virol. 68:1994;1265-1270.
18. Gilles PN, Fey G, Chisari FV. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J Virol. 66:1992;3955-3960.
19. Guidotti LG, Borrow P, Hobbs MV, Matzke B, Gresser I, Oldstone M, et al. Viral cross talk: Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci USA. 93:1996;4589-4594.
20. Guilhot S, Guidotti LG, Chisari FV. Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism. J Virol. 67:1993;7444-7449.
21. Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature. 281:1979;646-650.
22. Cha J, Bishai W, Chandrasegaran S. New vectors for direct cloning of PCR products. Gene. 136:1993;369-370.
23. Berger J, Hauber J, Hauber R, Geiger R, Cullen BR. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene. 66:1988;1-10.
24. Grötzinger T, Jensen K, Will H. The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-gamma activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J Biol Chem. 271:1996;25253-25260.
25. Thomis DC, Doohan JP, Samuel CE. Mechanism of interferon action: cDNA structure, expression of the interferon-induced, RNA-dependent P1/eIF-2α protein kinase from human cells. Virology. 188:1992;33-46.
26. Acs G, Sells MA, Purcell RH, Price P, Engle R, Shapiro M, et al. Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc Natl Acad Sci USA. 84:1987;4641-4644.
27. Chang CM, Jeng KS, Hu CP, Lo SJ, Su TS, Ting LP, et al. Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line. EMBO J. 6:1987;675-680.
28. Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA. 84:1987;1005-1009.
29. Su H, Yee JK. Regulation of hepatitis B virus gene expression by its two enhancers. Proc Natl Acad Sci USA. 89:1992;2708-2712.
30. Romero R, Lavine JE. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology. 23:1996;17-23.
31. Lavine JE, Ganem D. Inhibition of duck hepatitis B virus replication by interferon-gamma. J Med Virol. 40:1993;59-64.
32. Heise T, Guidotti LG, Cavanaugh VJ, Chisari F. Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol. 73:1999;474-481.
33. Raymond V, Atwater JA, Verma IM. Removal of an mRNA destabilizing element correlates with the increased oncogenicity of proto-oncogene fos. Oncogene Res. 5:1989;1-12.
34. Chen CY, Xu N, Shyu AB. mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol Cell Biol. 15:1995;5777-5788.
35. Zubiaga AM, Belasco JG, Greenberg ME. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol. 15:1995;2219-2230.